475 related articles for article (PubMed ID: 29360619)
1. Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology.
Whyte MP; Coburn SP; Ryan LM; Ericson KL; Zhang F
Bone; 2018 May; 110():96-106. PubMed ID: 29360619
[TBL] [Abstract][Full Text] [Related]
2. Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B
Whyte MP; Zhang F; Mack KE; Wenkert D; Gottesman GS; Ericson KL; Cole JT; Coburn SP
Bone; 2024 Apr; 181():117033. PubMed ID: 38307176
[TBL] [Abstract][Full Text] [Related]
3. Hypophosphatasia: Vitamin B
Whyte MP; Zhang F; Wenkert D; Mack KE; Bijanki VN; Ericson KL; Coburn SP
Bone; 2022 Jan; 154():116204. PubMed ID: 34547524
[TBL] [Abstract][Full Text] [Related]
4. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients.
Whyte MP; Zhang F; Wenkert D; McAlister WH; Mack KE; Benigno MC; Coburn SP; Wagy S; Griffin DM; Ericson KL; Mumm S
Bone; 2015 Jun; 75():229-39. PubMed ID: 25731960
[TBL] [Abstract][Full Text] [Related]
5. Hypophosphatasia: An overview For 2017.
Whyte MP
Bone; 2017 Sep; 102():15-25. PubMed ID: 28238808
[TBL] [Abstract][Full Text] [Related]
6. Hypophosphatasia: Natural history study of 101 affected children investigated at one research center.
Whyte MP; Wenkert D; Zhang F
Bone; 2016 Dec; 93():125-138. PubMed ID: 27576207
[TBL] [Abstract][Full Text] [Related]
7. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
Whyte MP
J Bone Miner Res; 2017 Apr; 32(4):667-675. PubMed ID: 28084648
[TBL] [Abstract][Full Text] [Related]
8. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.
Whyte MP
Nat Rev Endocrinol; 2016 Apr; 12(4):233-46. PubMed ID: 26893260
[TBL] [Abstract][Full Text] [Related]
9. Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia.
Whyte MP; Zhang F; Wenkert D; Mumm S; Berndt TJ; Kumar R
Bone; 2020 May; 134():115300. PubMed ID: 32112990
[TBL] [Abstract][Full Text] [Related]
10. Vitamin B
Whyte MP; May JD; McAlister WH; Burgener K; Cortez SR; Kreienkamp R; Castro O; Verzola R; Zavala AS; McPherson CC; Gottesman GS; Ericson KL; Coburn SP; Arbelaez AM
Bone; 2021 Sep; 150():116007. PubMed ID: 34000433
[TBL] [Abstract][Full Text] [Related]
11. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.
Whyte MP; McAlister WH; Mumm S; Bierhals AJ
Bone; 2019 May; 122():231-236. PubMed ID: 30825650
[TBL] [Abstract][Full Text] [Related]
12. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene.
Baumgartner-Sigl S; Haberlandt E; Mumm S; Scholl-Bürgi S; Sergi C; Ryan L; Ericson KL; Whyte MP; Högler W
Bone; 2007 Jun; 40(6):1655-61. PubMed ID: 17395561
[TBL] [Abstract][Full Text] [Related]
13. Physiological role of alkaline phosphatase explored in hypophosphatasia.
Whyte MP
Ann N Y Acad Sci; 2010 Mar; 1192():190-200. PubMed ID: 20392236
[TBL] [Abstract][Full Text] [Related]
14. Healing of vitamin D deficiency rickets complicating hypophosphatasia suggests a role beyond circulating mineral sufficiency for vitamin D in musculoskeletal health.
Lin EL; Gottesman GS; McAlister WH; Bijanki VN; Mack KE; Griffin DM; Mumm S; Whyte MP
Bone; 2020 Jul; 136():115322. PubMed ID: 32200022
[TBL] [Abstract][Full Text] [Related]
15. Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa.
Kishnani PS; Del Angel G; Zhou S; Rush ET
Mol Genet Metab; 2021 May; 133(1):113-121. PubMed ID: 33814268
[TBL] [Abstract][Full Text] [Related]
16. Hypophosphatasia: A Unique Disorder of Bone Mineralization.
Villa-Suárez JM; García-Fontana C; Andújar-Vera F; González-Salvatierra S; de Haro-Muñoz T; Contreras-Bolívar V; García-Fontana B; Muñoz-Torres M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919113
[TBL] [Abstract][Full Text] [Related]
17. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
Kishnani PS; Rockman-Greenberg C; Rauch F; Bhatti MT; Moseley S; Denker AE; Watsky E; Whyte MP
Bone; 2019 Apr; 121():149-162. PubMed ID: 30576866
[TBL] [Abstract][Full Text] [Related]
18. Hypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature review).
Wenkert D; McAlister WH; Coburn SP; Zerega JA; Ryan LM; Ericson KL; Hersh JH; Mumm S; Whyte MP
J Bone Miner Res; 2011 Oct; 26(10):2389-98. PubMed ID: 21713987
[TBL] [Abstract][Full Text] [Related]
19. "Atypical femoral fractures" during bisphosphonate exposure in adult hypophosphatasia.
Sutton RA; Mumm S; Coburn SP; Ericson KL; Whyte MP
J Bone Miner Res; 2012 May; 27(5):987-94. PubMed ID: 22322541
[TBL] [Abstract][Full Text] [Related]
20. Novel mouse model of autosomal semidominant adult hypophosphatasia has a splice site mutation in the tissue nonspecific alkaline phosphatase gene Akp2.
Hough TA; Polewski M; Johnson K; Cheeseman M; Nolan PM; Vizor L; Rastan S; Boyde A; Pritzker K; Hunter AJ; Fisher EM; Terkeltaub R; Brown SD
J Bone Miner Res; 2007 Sep; 22(9):1397-407. PubMed ID: 17539739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
